|
Delayed
NSE India S.E.
22:59:37 2026-11-08 EST
|
5-day change | 1st Jan Change | ||
| 767.90 INR | +0.13% |
|
+0.83% | -13.14% |
| 11-06 | Fortis Healthcare Limited, Q2 2027 Earnings Call, Nov 06, 2026 | |
| 11-05 | Fortis Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
Company Valuation: Fortis Healthcare Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 219,240 | 196,214 | 317,233 | 527,225 | 600,192 | 584,073 | - | - |
| Change | - | -10.5% | 61.68% | 66.19% | 13.84% | -2.69% | - | - |
| Enterprise Value (EV) 1 | 224,770 | 199,618 | 322,800 | 546,896 | 629,308 | 603,401 | 596,298 | 587,452 |
| Change | - | -11.19% | 61.71% | 69.42% | 15.07% | -4.12% | -1.18% | -1.48% |
| P/E | 39.5x | 33.3x | 53x | 68.1x | 57.6x | 47.8x | 34.4x | 27.2x |
| PBR | 3.55x | 2.71x | 4.14x | 5.91x | 6.07x | 5.3x | 4.62x | 4.03x |
| PEG | - | 5.44x | 31.8x | 2.3x | 1.7x | 2.8x | 0.9x | 1x |
| Capitalization / Revenue | 3.83x | 3.12x | 4.6x | 6.77x | 6.58x | 5.43x | 4.72x | 4.11x |
| EV / Revenue | 3.93x | 3.17x | 4.68x | 7.03x | 6.89x | 5.61x | 4.82x | 4.14x |
| EV / EBITDA | 20.6x | 18.1x | 25.5x | 34.4x | 30.2x | 24.9x | 20.1x | 16.7x |
| EV / EBIT | 28.4x | 25.4x | 34.9x | 45.5x | 38.5x | 31.3x | 24.3x | 19.9x |
| EV / FCF | 30x | 53.2x | 205x | 94.8x | 95.9x | 45.3x | 40.5x | 29.2x |
| FCF Yield | 3.34% | 1.88% | 0.49% | 1.06% | 1.04% | 2.21% | 2.47% | 3.42% |
| Dividend per Share 2 | - | 1 | 1 | 1 | 1 | 1.157 | 1.551 | 1.719 |
| Rate of return | - | 0.38% | 0.24% | 0.14% | 0.13% | 0.15% | 0.2% | 0.22% |
| EPS 2 | 7.35 | 7.8 | 7.93 | 10.26 | 13.8 | 16.18 | 22.47 | 28.42 |
| Distribution rate | - | 12.8% | 12.6% | 9.75% | 7.25% | 7.15% | 6.9% | 6.05% |
| Net sales 1 | 57,176 | 62,976 | 68,929 | 77,828 | 91,278 | 107,512 | 123,693 | 142,034 |
| EBITDA 1 | 10,931 | 11,013 | 12,676 | 15,879 | 20,850 | 24,195 | 29,735 | 35,214 |
| EBIT 1 | 7,923 | 7,856 | 9,251 | 12,023 | 16,356 | 19,282 | 24,552 | 29,493 |
| Net income 1 | 5,551 | 5,887 | 6,011 | 7,742 | 10,418 | 12,167 | 16,781 | 21,008 |
| Net Debt 1 | 5,530 | 3,404 | 5,566 | 19,671 | 29,116 | 19,328 | 12,225 | 3,379 |
| Reference price 2 | 290.40 | 259.90 | 420.20 | 698.35 | 795.00 | 773.65 | 773.65 | 773.65 |
| Nbr of stocks (in thousands) | 754,958 | 754,958 | 754,958 | 754,958 | 754,958 | 754,958 | - | - |
| Announcement Date | 5/25/22 | 5/23/23 | 5/23/24 | 5/20/25 | 5/22/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 47.62x | 5.57x | 24.7x | 0.15% | 6.16B | |
| 11.81x | 0.38x | 7.78x | 3.18% | 107B | |
| 16.35x | 1.95x | 9.69x | 0.63% | 103B | |
| -184.73x | 14.51x | -243.19x | -.--% | 45.05B | |
| 16.04x | 1.7x | 10.2x | 2.17% | 32.96B | |
| 27.36x | 2.36x | 13.38x | 0.79% | 29.77B | |
| 24.76x | 2.74x | 13.91x | 1.29% | 28.12B | |
| 7.79x | 1.48x | 6.52x | -.--% | 22.55B | |
| 29.77x | 5.31x | 21.77x | 2.35% | 20.12B | |
| 29.8x | 2.82x | 12.67x | 1.49% | 16.76B | |
| Average | 2.66x | 3.88x | -12.26x | 1.21% | 41.22B | |
| Weighted average by Cap. | -4.26x | 3.21x | -17.09x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- FORTIS Stock
- Valuation Fortis Healthcare Limited
Select your edition
All financial news and data tailored to specific country editions
